Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors
PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Study Completion Date
September 30, 2000
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG
paclitaxel
DRUG
topotecan hydrochloride
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Jonsson Comprehensive Cancer Center
OTHER
NCT00004979 - Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors | Biotech Hunter | Biotech Hunter